BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18000611)

  • 1. Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins.
    Wielders SJ; Ungethüm L; Reutelingsperger CP; Bevers EM; Lindhout T
    Thromb Haemost; 2007 Nov; 98(5):1056-62. PubMed ID: 18000611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets.
    Briedé JJ; Heemskerk JW; van't Veer C; Hemker HC; Lindhout T
    Thromb Haemost; 2001 Mar; 85(3):509-13. PubMed ID: 11307823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
    Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
    Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface.
    Majumder R; Weinreb G; Lentz BR
    Biochemistry; 2005 Dec; 44(51):16998-7006. PubMed ID: 16363813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.
    Dasgupta SK; Guchhait P; Thiagarajan P
    Transl Res; 2006 Jul; 148(1):19-25. PubMed ID: 16887494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
    Koklic T; Chattopadhyay R; Majumder R; Lentz BR
    Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.
    Hoekema L; Nicolaes GA; Hemker HC; Tans G; Rosing J
    Biochemistry; 1997 Mar; 36(11):3331-5. PubMed ID: 9116011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
    Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
    Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.
    Stuart MC; Bevers EM; Comfurius P; Zwaal RF; Reutelingsperger CP; Frederik PM
    Thromb Haemost; 1995 Oct; 74(4):1145-51. PubMed ID: 8560427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets and phospholipids in tissue factor-initiated thrombin generation.
    Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG
    Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
    Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
    Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FVIII binding to PS membranes differs in the activated and non-activated form and can be shielded by annexin A5.
    Engelke H; Lippok S; Dorn I; Netz RR; Rädler JO
    J Phys Chem B; 2011 Nov; 115(44):12963-70. PubMed ID: 21954889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death.
    Shi J; Shi Y; Waehrens LN; Rasmussen JT; Heegaard CW; Gilbert GE
    Cytometry A; 2006 Dec; 69(12):1193-201. PubMed ID: 17123296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
    Koshiar RL; Somajo S; Norström E; Dahlbäck B
    PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
    Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
    Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
    Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.